QLY Biotech Group Corp.
QLY Biotech Group Corp. engages in the tourism business in the Dominican Republic. It organizes individual and group sailing tours. The company was formerly known as Azar International Corp. and changed its name to QLY Biotech Group Corp. in August 2022. QLY Biotech Group Corp. was incorporated in 2018 and is based in Las Vegas, Nevada.
QLY Biotech Group Corp. (LQLY) - Total Liabilities
Latest total liabilities as of February 2023: $19.67K USD
Based on the latest financial reports, QLY Biotech Group Corp. (LQLY) has total liabilities worth $19.67K USD as of February 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
QLY Biotech Group Corp. - Total Liabilities Trend (2019–2022)
This chart illustrates how QLY Biotech Group Corp.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
QLY Biotech Group Corp. Competitors by Total Liabilities
The table below lists competitors of QLY Biotech Group Corp. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Atco Mining Inc.
PINK:ATMGF
|
USA | $216.97K |
|
Golf & Co Group Ltd
TA:GOLF
|
Israel | ILA864.76 Million |
|
Central Petroleum Limited
PINK:CNPTF
|
USA | $73.11 Million |
|
GP Global Power Ltd
TA:GPGB
|
Israel | ILA118.52 Million |
|
MGT Capital Investments Inc
PINK:MGTI
|
USA | $2.37 Million |
|
MAYR-MELNHOF KARTON - Dusseldorf Stock Exchang
DU:MYM
|
Germany | €2.89 Billion |
|
Freedom Holdings Inc
PINK:FHLD
|
USA | $30.92 Million |
|
WEBUY GLOBAL LTD. Ordinary Shares
NASDAQ:WBUY
|
USA | $14.24 Million |
Liability Composition Analysis (2019–2022)
This chart breaks down QLY Biotech Group Corp.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | N/A | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how QLY Biotech Group Corp.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for QLY Biotech Group Corp. (2019–2022)
The table below shows the annual total liabilities of QLY Biotech Group Corp. from 2019 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-08-31 | $0.00 | -- |
| 2021-08-31 | $13.12K | +68.30% |
| 2020-08-31 | $7.80K | +161.82% |
| 2019-08-31 | $2.98K | -- |